• SeaStar Medical held its annual shareholder meeting on June 17, 2026.
• Shareholders adopted an amended and restated 2022 Omnibus Incentive Plan, lifting authorized common shares under the plan to 896,546 from 207,046.
• Shareholders ratified WithumSmith+Brown as independent registered public accounting firm for the fiscal year ending Dec. 31, 2026.
• Shareholders also authorized an adjournment or postponement of the meeting if needed to solicit additional proxies.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Seastar Medical Holding Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-020967), on June 17, 2026, and is solely responsible for the information contained therein.